This content is machine translated Mechanisms, evidence and therapeutic consequences GLP-1 receptor agonists in cardiology GLP-1 receptor agonists (GLP-1RAs) have rapidly evolved from antidiabetic drugs to cardiometabolic therapies with clinically proven reductions in hard cardiovascular endpoints – and increasingly beyond the traditional diabetes population. The...…
View Post 4 min This content is machine translated Parkinson's disease Individualized therapy concepts are essential After Alzheimer’s disease, Parkinson’s disease is currently the second most common neurodegenerative disease. The majority of those affected are ≥60 years old when it first manifests, but a minority develop...…
